ACADIA Pharmaceuticals Inc (ACAD)

Add to Watchlists
Create an Alert
Quickflows
24.25 -0.63  -2.53% NASDAQ Jun 23, 10:39 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ACAD News

News

View All Events

Events

Date Type Description
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/04/2020 Earnings Results Q3 2020 Earnings Results
11/04/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 16:30 EST Earnings Calls Q2 2020 Earnings Call
08/05/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 458.24M
Total Expenses (TTM) 722.08M
Net Income (TTM) -260.01M

Balance Sheet View Statement

Total Assets (Quarterly) 755.17M
Total Liabilities (Quarterly) 173.57M
Shareholders Equity (Quarterly) 581.61M

Cash Flow Statement View Statement

Cash from Operations (TTM) -147.31M
Cash from Investing (TTM) 193.78M
Cash from Financing (TTM) 84.97M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
  • URL: https://www.acadia-pharm.com
  • Investor Relations URL: https://ir.acadia-pharm.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 24.25
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
FBT First Trust NYSE Arca Biotech ETF 3.67%
F0000144EU FT Biotechnology 46 CA 2.61%
SBIO ALPS Medical Breakthroughs ETF 2.38%
F000015MKJ FT Biotechnology 50 F CA 2.20%
ASYMX Alger Weatherbie Specialized Growth Y 2.06%
AIM9000 Invesco Global Focus Fund Series O 2.02%
AIM41761 Invesco Global Focus Class Series PH 2.01%
APDHX Artisan Global Equity Advisor 1.36%
BTAL AGFiQ US Market Neutral Anti-Beta 0.52%

Comparables

Edit
FGEN FibroGen Inc
EBS Emergent BioSolutions Inc
KRMD Repro-Med Systems Inc
KDMN Kadmon Holdings Inc
PRVB Provention Bio Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.